版本:
中国

ICU Medical to buy Pfizer's infusion therapy business for $1 bln

Oct 6 Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock.

Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical common stock. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Martina D'Couto)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐